CA - 908 Devices: Rare Early-Stage Bioprocess Investment Opportunity

2024-04-10 12:49:59 ET

Summary

• Thermo Fisher Scientific, Danaher Corporation, and Agilent Technologies are leading companies in the life science tools industry.
• Despite a long history of success with those firms, I believe long-term investors should diversify into growth opportunities that underlie the industry.
• 908 Devices, Inc. is a promising company focused on first-in-class mass spectrometry and bioprocess analysis tools, with a profitable future in store.

Introduction

While much of the publicity of the healthcare industry revolves around pioneering new life saving therapies, new frontiers cannot be manifested without proper research instrument technological advancement. As the foundation of the healthcare industry, life science tools are essential for modern biopharma companies to operate, and companies such as Thermo Fisher Scientific, Inc ( TMO ), Danaher Corporation ( DHR ), and Agilent Technologies, Inc ( A ) highlight the lucrative opportunities that exist. Remove any of these companies from existence, and we would reverse decades of scientific advancement....

For further details see: